Prognostic factors of childhood acute lymphoblastic leukemia with TCF3::PBX1 in CCCG‐ALL‐2015: A multicenter study

Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia

(2022) Shawn H. R. Lee et al.   JAMA Oncology

Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial

(2022) Tianyi Wang et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Factors for CNS Control in Children with Acute Lymphoblastic Leukemia Treated Without Cranial Irradiation

(2021) Jingyan Tang et al.   BLOOD

Clinical features and prognostic impact of TCF3–PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China

(2021) Ming Jia et al.   CURRENT PROBLEMS IN CANCER

The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A‐PBX1 : A 10‐year retrospective study

(2021) Biqi Zhou et al.   AMERICAN JOURNAL OF HEMATOLOGY

Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T cell therapy

(2021) Allison Barz Leahy et al.   BLOOD

Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia

(2020) Hiroo Ueno et al.   Blood Advances

Treatment of testicular relapse of B-cell acute lymphoblastic leukemia with CD19-specific chimeric antigen receptor T cells

(2019) Xiaojuan Chen et al.   Clinical Lymphoma Myeloma & Leukemia

Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16

(2019) Sima Jeha et al.   JOURNAL OF CLINICAL ONCOLOGY

Excellent outcome of acute lymphoblastic leukaemia with TCF3-PBX1 rearrangement in Hong Kong

(2018) Anna Lin et al.   PEDIATRIC BLOOD & CANCER

Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia

(2017) N Toft et al.   LEUKEMIA

Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group

(2016) Rob Pieters et al.   JOURNAL OF CLINICAL ONCOLOGY

E2A-PBX1 exhibited a promising prognosis in pediatric acute lymphoblastic leukemia treated with the CCLG-ALL2008 protocol

(2016) Yixin Hu et al.   OncoTargets and Therapy

Prevalence of common fusion transcripts in acute lymphoblastic leukemia: A report of 304 cases

(2015) Anita Chopra et al.   Asia-Pacific Journal of Clinical Oncology

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

(2015) Ching-Hon Pui et al.   JOURNAL OF CLINICAL ONCOLOGY

Acute Lymphoblastic Leukemia in Children

(2015) Stephen P. Hunger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1

(2009) S Jeha et al.   LEUKEMIA